DK0443598T3 - Blodkoagulationsinhiberende peptider, fremgangsmåde til deres fremstilling samt deres anvendelse - Google Patents

Blodkoagulationsinhiberende peptider, fremgangsmåde til deres fremstilling samt deres anvendelse

Info

Publication number
DK0443598T3
DK0443598T3 DK91102607.8T DK91102607T DK0443598T3 DK 0443598 T3 DK0443598 T3 DK 0443598T3 DK 91102607 T DK91102607 T DK 91102607T DK 0443598 T3 DK0443598 T3 DK 0443598T3
Authority
DK
Denmark
Prior art keywords
glu
asp
atoms
phe
bond
Prior art date
Application number
DK91102607.8T
Other languages
Danish (da)
English (en)
Inventor
Werner Dr Stueber
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of DK0443598T3 publication Critical patent/DK0443598T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91102607.8T 1990-02-22 1991-02-22 Blodkoagulationsinhiberende peptider, fremgangsmåde til deres fremstilling samt deres anvendelse DK0443598T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4005591A DE4005591A1 (de) 1990-02-22 1990-02-22 Die blutgerinnung inhibierende peptide, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
DK0443598T3 true DK0443598T3 (da) 1995-09-25

Family

ID=6400736

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91102607.8T DK0443598T3 (da) 1990-02-22 1991-02-22 Blodkoagulationsinhiberende peptider, fremgangsmåde til deres fremstilling samt deres anvendelse

Country Status (11)

Country Link
EP (1) EP0443598B1 (es)
JP (1) JPH0770181A (es)
KR (1) KR910021412A (es)
AT (1) ATE122684T1 (es)
AU (1) AU640739B2 (es)
CA (1) CA2036815A1 (es)
DE (2) DE4005591A1 (es)
DK (1) DK0443598T3 (es)
ES (1) ES2073601T3 (es)
IE (1) IE66493B1 (es)
PT (1) PT96836B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4103649A1 (de) * 1991-02-07 1992-08-13 Basf Ag Neue antikoagulatorisch wirksame peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341032C (en) * 1987-01-23 2000-06-20 John L. Krstenansky Anticoagulant peptides
AU6054090A (en) * 1989-07-20 1991-02-22 Biogen, Inc. Combinations and methods for treating or preventing thrombotic diseases
WO1991002348A1 (en) * 1989-08-07 1991-02-21 Motorola, Inc. Speech recognition using spectral line frequencies
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin

Also Published As

Publication number Publication date
KR910021412A (ko) 1991-12-20
DE59105479D1 (de) 1995-06-22
IE66493B1 (en) 1996-01-10
ES2073601T3 (es) 1995-08-16
ATE122684T1 (de) 1995-06-15
EP0443598A2 (de) 1991-08-28
EP0443598B1 (de) 1995-05-17
AU7125591A (en) 1991-08-29
PT96836A (pt) 1991-10-31
DE4005591A1 (de) 1991-09-05
CA2036815A1 (en) 1991-08-23
PT96836B (pt) 1998-07-31
EP0443598A3 (en) 1992-01-08
IE910597A1 (en) 1991-08-28
JPH0770181A (ja) 1995-03-14
AU640739B2 (en) 1993-09-02

Similar Documents

Publication Publication Date Title
CA2050300A1 (en) Tnf-inhibiting proteins and the preparation thereof
ES2041611T1 (es) Un pentapeptido ciclico y su procedimiento de preparacion.
KR880009045A (ko) 혈액 응고 방지성 펩티드
ES2054842T3 (es) Analogo del factor viii, procedimiento de preparacion y composicion farmaceutica que lo contiene.
HUP0003592A2 (hu) LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények
DE3486154D1 (de) Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung.
KR910007959A (ko) 방사성 동위원소로 표지된 항응고성 펩티드
ATE171712T1 (de) Neuartiger menschlicher proteaseinhibitor vom kunitz-typ und entsprechende varianten
KR880013977A (ko) 항응고제인 사이클릭 펩타이드
Lemaire et al. Synthesis and biological activity of. beta.-endorphin and analogs. Additional evidence for multiple opiate receptors
DK0443598T3 (da) Blodkoagulationsinhiberende peptider, fremgangsmåde til deres fremstilling samt deres anvendelse
ES2056753A6 (es) Un procedimiento para la produccion de un polipeptido que tiene actividad de factor quemotactico de monocitos humanos.
DK162130C (da) Grf-analoge peptider, fremgangsmaade til fremstilling deraf, grf-analoge peptider som terapeutiske midler, anvendelse af grf-analoge peptider, fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende grf-analoge peptider samt parenterale farmaceutiske praeparater indeholdende grf-analoge peptider
CA2026376A1 (en) Anticoagulant peptides
NZ334714A (en) Liver proteins as agents against autoimmune diseases
Goodwin et al. Microheterogeneity in a non-histone chromosomal protein
PAUKOVITS et al. Structural investigations on a peptide regulating hemopoiesis in vitro and in vivo
SE8603546L (sv) Polypeptider och framstellningsforfarande derav
EP0292257A3 (en) Peptides having anf activity
ATE84042T1 (de) Peptide.
EP0232435A3 (en) Serum thymic factor peptide analogs and a process for the preparation thereof
Ramponi et al. Labelling of non C-terminal glutamic acid during C-terminal analysis by the tritiation method when the γ-glutamyl-peptide linkage is present
Buku et al. Synthesis and biological activities of arginine-vasopressin analogs with 4-hydroxyproline in position 7
Lopez-Trascasa et al. Isolation and characterization of a biologically active C2 derived oligopeptide
ES437091A1 (es) Procedimiento para la fabricacion de peptidos.